Previous studies mainly focused on the aberrant expression of AKR1C3 and its biological activity in castrate resistant prostate cancer (CRPC) [29], whereas the potential effects AKR1C3 gene exerts on the radioresiatance of PCa was unclear. This evidence concerns the gene AKR1C3 and posterior cortical atrophy.